EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular Docking-Based Binding Mode Analysis

Inji Jung, Dinesh Kumar Sriramulu iD, Sun-Gu Lee iD, Sang Taek Jung iD

ACS Synthetic Biology · 2025

DOI: 10.1021/acssynbio.5c00425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2025. Verfasst von Inji Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Graduate School, Korea University, Seoul 02707, Republic of Korea. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus, Antibodies, Viral. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Drug Development Fund, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingSpike Glycoprotein, CoronavirusAntibodies, ViralSARS-CoV-2Molecular Docking SimulationDirected Molecular EvolutionHumansSingle-Chain AntibodiesCOVID-19Protein Binding

Stichwörter der Autor:innen

SARS-CoV-1SARS-CoV-2antibody reprogrammingcomputational modelingdirected evolution

Substanzen

Antibodies, NeutralizingSpike Glycoprotein, CoronavirusAntibodies, ViralSingle-Chain Antibodiesspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Graduate School, Korea University, Seoul 02707, Republic of Korea.
  • BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02707, Republic of Korea.
  • School of Chemical and Biological Engineering, Seoul National University, Seoul 08826, Republic of Korea.
  • Department of Chemical Engineering, Pusan National University, Busan 46241, Republic of Korea.
  • Interdisciplinary Program for Bioengineering, Seoul National University, Seoul 08826, Republic of Korea.
  • Institute of Chemical Processes, Seoul National University, Seoul 08826, Republic of Korea.

ORCID-Profile: Dinesh Kumar Sriramulu, Sun-Gu Lee, Sang Taek Jung

Förderung

  • Korea Drug Development Fund
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Jung, I., Sriramulu, D. K., Lee, S. G., & Jung, S. T. (2025). Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular Docking-Based Binding Mode Analysis. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.5c00425

Vancouver

Jung I, Sriramulu DK, Lee SG, Jung ST. Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular Docking-Based Binding Mode Analysis. ACS Synthetic Biology. 2025. doi:10.1021/acssynbio.5c00425

BibTeX
@article{Jung2025,
  author = {Jung, Inji and Sriramulu, Dinesh Kumar and Lee, Sun-Gu and Jung, Sang Taek},
  title = {Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular Docking-Based Binding Mode Analysis},
  journal = {ACS Synthetic Biology},
  year = {2025},
  doi = {10.1021/acssynbio.5c00425}
}
Kostenlos starten →